1) Fiacitabine
非西他滨
2) gemcitabine
吉西他滨
1.
Preparation of gemcitabine polybutylcyanoacrylate nanoparticles;
吉西他滨聚氰基丙烯酸正丁酯纳米粒的制备工艺
2.
Low Dose Gemcitabine Combined Nedaplatin for Advanced Nonsmall-cell Lung Cancer:Observation of Curative Effect;
低剂量吉西他滨联合奈达铂治疗晚期非小细胞肺癌疗效观察
3.
Clinical Observation of Gemcitabine Combined with Cisplatin for Distant Metastatic Nasopharyngeal Carcinoma Patients;
吉西他滨联合顺铂治疗鼻咽癌远处转移的临床研究
3) decitabine
地西他滨
1.
Effects of Decitabine on the methylation status and mRNA expression of ERα gene in cultured rat vascular smooth muscle cells
地西他滨对体外培养大鼠的血管平滑肌细胞ERα基因启动子甲基化状态及mRNA表达的影响
2.
The effects and the mechanisms of demethylating agent Decitabine and/or ATRA on SKM-1 cells in vitro
地西他滨联合全反式维甲酸对SKM-1 MDS细胞株的体外研究
3.
The study was purposed to explore the effect and mechanisms of decitabine and/or Trichostatin A(TSA) on SKM-1 cells in vitro.
本研究探讨去甲基化制剂地西他滨(decitabine)和(或)组蛋白去乙酰化酶抑制剂曲古抑菌素A(TSA)对MDS-RAEB细胞株SKM-1的影响及作用机制。
4) gemcitabin
吉西他滨
1.
A Clinical Study on Gemcitabin Combined with Oxaliplatin in the Treatment of Advanced Non-small Cell Lung Cancer;
吉西他滨联合奥沙利铂治疗晚期非小细胞肺癌
2.
Respective Study of the Incidence of Skin Rash Induced by Domestic and Imported Gemcitabin;
国产与进口吉西他滨皮疹发生率的回顾分析
3.
We studied the efficacy and toxicity of gemcitabin plus capecitabine in the treatment of the patients with advanced breast cancer who had failed in response to the treatment of anthracyclin and taxanes ch.
本研究探讨既往接受过蒽环类和紫杉类药物治疗失败的晚期乳腺癌患者,使用吉西他滨联合卡培他滨方案治疗的疗效和毒性。
5) Zalcitabine
[英][zæl'sitəbi:n] [美]['zælsɪtə,baɪn]
扎西他滨
6) Ancitabine;Cyclocytidine
安西他滨
补充资料：吉西他滨
分子式：C9H11F2N3O4
分子量：263.20
CAS号：95058-81-4
性质：暂无
制备方法：暂无
用途：用于晚期和转移性胰腺癌。
分子量：263.20
CAS号：95058-81-4
性质：暂无
制备方法：暂无
用途：用于晚期和转移性胰腺癌。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条